Home About Us Contact Us

 

Table of Content - Volume 19 Issue 3 - September 2021


 

Study of effect of pneumoperitoneum on hemodynamic parameters and cardiac function in patients undergoing laparoscopic cholecystectomy with and without cardiac disease

 

Varsha Sapehia1, Kamlesh2*, Prerna Verma3, Kajal Jain4, Tanvir Samra5, Komal Ghandhi6, lileshwar Kaman7

 

1Junior Resident, 3,6Assistant Professor, 4Professor, 5Associate Professor, Department of Anaesthesia & Intensive Care}

{7Professor, Department of General Surgery} PGIMER, Chandigarh, INDIA.

2Junior Resident, Department of Obstetrics & Gynaecology, Kamla Nehru Hospital, Shimla, Himachal Pradesh, INDIA.

Email: varshasapehia@gmail.com

 

Abstract              Background: Gold standard surgical treatment for gallstone disease is Laparoscopic cholecystectomy. Over the years surgical skills have been improved and also there is better understanding of pneumoperitoneum3 Pneumoperitoneum stimulate a neuro-hormonal stress response which lead to increases heart rate, mean arterial blood pressure and systemic vascular resistance. Present study was designed to study the effect of pneumoperitoneum on hemodynamic parameters and cardiac function in patients undergoing laparoscopic cholecystectomy with and without cardiac disease. Material and Methods: Present study was prospective, comparative study, conducted in department of anaesthesiology. Study group was patients 18-65 years age, with echocardiographic findings consistent with presence of moderate to severe left ventricular systolic dysfunction, planned for laparoscopic cholecystectomy, Consented for participation, while control group was patients 18-65 years age, with normal echocardiographic finding, planned for laparoscopic cholecystectomy, Consented for participation. Results: Total 30 patients were enrolled in this prospective trial; 15 in each group. (Study and control group). The mean age of patients are 55.6 years and 36.6 years in study and control group, respectively and difference was statistically significant. Sex distribution: In control group, male: female distribution is 1:1.2; while in the study group, male: female distribution is 1:4, and difference was statistically significant. On intragroup statistical analysis, in the control group a statistically significant fall in HR is noticed at T2 and T4 from T1. Conclusion: Present study showed that laparoscopic cholecystectomy may be safely done in cardiac patients with moderate to severe left ventricular systolic dysfunction patients under the supervision of an experienced consultant anaesthesiologist.

Keywords: laparoscopic cholecystectomy, left ventricular systolic dysfunction, balanced anaesthesia, pneumoperitoneum

 

INTRODUCTION

Gold standard surgical treatment for gallstone disease is Laparoscopic cholecystectomy. Laparoscopic cholecystectomy procedure results cosmetically more acceptable, decreased hospital duration, less postoperative pain and lesser disability from daily work as compared to open cholecystectomy.1 Over the years surgical skills have been improved and also there is better understanding of pneumoperitoneum3 Pneumoperitoneum stimulate a neuro-hormonal stress response which lead to increases heart rate, mean arterial blood pressure and systemic vascular resistance. 2 Laparoscopic surgeries using carbon dioxide for inflating the abdomen have serious impacts on various systems including cardiovascular system.4 Both the anaesthetist and surgeon are anxious in these patients therefore laparoscopic cholecystectomy is mostly avoided in these patients.4 On the opposite hand , patients with laparoscopic cholecystectomy , experience less physiological stress as compared to those who underwent open surgery. 1 The dilemma still continues, whether the laparoscopic cholecystectomy be beneficial in patients having cardiac dysfunction as the advantage will be less physiological stress and disadvantage of pneumoperitoneum will be there. Present study was designed to study the effect of pneumoperitoneum on hemodynamic parameters and cardiac function in patients undergoing laparoscopic cholecystectomy with and without cardiac disease.

              

MATERIAL AND METHODS

Present study was prospective, comparative study, conducted in Department of Anaesthesia & Intensive Care, PGIMER, Chandigarh, India. Study duration was of 1 year (April, 2019 to March, 2020). Institutional ethical committee approval was obtained prior to start of study.

Inclusion criteria: Study group - Patients 18-65 years age, with echocardiographic findings consistent with presence of moderate to severe left ventricular systolic dysfunction, planned for laparoscopic cholecystectomy, Consented for participation. Control group - Patients 18-65 years age, with normal echocardiographic finding, planned for laparoscopic cholecystectomy, Consented for participation

Exclusion criteria: BMI > 35 kg/m2. Coexisting stenotic valve lesions or right ventricular dysfunction. Presence of electrocardiographic findings of arrhythmia. NYHA IV physical status. End stage hepatic/renal/pulmonary disease.

Study was explained Apart from the demographic variables, history of cardiac medications and prior history of admission to the ER or cardiac adverse events was also noted. The echocardiography was done by an experienced cardiologist and LV systolic dysfunction was graded as mild (LVEF 41–45%), moderate (LVEF 36–40%), or severe (LVEF (35%).5

Pre-operative 8-hour fasting was advised. followed. Patients were informed on the day prior to the surgery about the study and a written informed consent was taken. In operation theatre, cardiac output, Invasive blood pressure monitoring and Systemic vascular resistance (both from 2D echo, FloTrac system), non-invasive blood pressure monitoring, heart rate, stroke volume variation, central venous pressure (right internal jugular vein canula connected to the pressure transducing system), systolic pressure variation, pulse pressure variation were noted at the predefined study time points. All study parameters were recorded at the following time points.

  • T1 - Pre-induction
  • T2 - 10 minute after induction
  • T3 - when pneumoperitoneum with intra-abdominal (IAP) pressure of 12mm Hg is achieved,
  • T4 - 10 minute after reverse Trendelenburg position,
  • T5 - 10 minute after deflation of pneumoperitoneum.

Under general anaesthesia, after creation of pneumoperitoneum, once IAP of 12mm Hg was achieved, 2D echocardiography was done (T2). Intraoperatively IAP was maintained to < 12 mmHg. Following this reverse Trendelenburg positioning was done. 10 min after the positioning the 2nd sample of ABG was taken. After 10 min after exsufflation (T5), third ABG sample was taken.

The surgery was done according to the standard protocol. If any complication was refractory to medical management or surgical conversion to open procedure was deemed necessary, the patient was excluded from the study. The adverse complications anticipated during creation of pneumoperitoneum and surgery were hemodynamic changes like hypotension, hypertension, and rhythm abnormalities The patient was shifted to PACU after fulfilling the criteria that patient was able to respond to verbal stimuli and ensuring that pain was adequately managed. All cardiac patients were followed till hospital discharge and any in hospital morbidity were noted. Data was collected and compiled using Microsoft Excel, analysed using SPSS 23.0 version. Group comparisons of values of data were made with Mann-Whitney test for 2 groups. For Normally distributed data Student t-test was applied to compare 2 groups. A P value < 0.05 was considered statistically significant.


 

RESULTS

Total 30 patients were enrolled in this prospective trial; 15 in each group. (Study and control group). The mean age of patients are 55.6 years and 36.6 years in study and control group, respectively and difference was statistically significant. Sex distribution: In control group, male: female distribution is 1:1.2; while in the study group, male: female distribution is 1:4, and difference was statistically significant. Other parameters like weight, height, BMI, BSA and duration of surgery were comparable in both groups and difference was not statistically significant.

 

Table 1: General characteristics of both groups

Parameter

Study group (N=15)

Control group (N=15)

P value

Age in years

55.57±7.52

36.57±9.55

0.001*

Sex (male/ female)

3/12

7/8

0.001*

Weight in kg

64.43±14.62

56.29±8.18

0.229

Height in cm

164.29±11.15

155.43±2.07

0.061

BMI in kg/m2

23.66±2.77

26.23±4.45

0.218

BSA in m2

1.7±0.25

1.55±0.13

0.196

Duration of pneumoperitoneum (min)

29.71±9.36

27.43±4.54

0.572

Medical comorbidities

 

 

 

Hypertension

12

 

 

Previous history of cardiac intervention

3

 

 

NYHA Class

 

 

 

II

3

 

 

III

12

 

 

Ejection fraction

 

 

 

30-40%

11

 

 

<30%

4

 

 

From T1 to T2, the decrease in mean HR is 6.5% in the study group as compared to 9.2% decrease in control group while at T3 clinically insignificant changes in mean HR from T2 are noticed in both the groups. On intragroup statistical analysis, in the control group a statistically significant fall in HR is noticed at T2 and T4 from T1.

 

Table 2: Heart rate in the two groups

Parameter

Study group (N=15)

Control group (N=15)

P value

 

Mean ± SD

P value from T1

Mean ± SD

P value from T1

HR at T1

81±10.82

-

83.71±9.91

-

0.633

HR at T2

75.71±12.84

.411

76±9.95

.000*

0.964

HR at T3

74.29±14.16

.338

80.29±6.65

.185

0.330

HR at T4

75.43±15.21

.464

76.43±5.03

.033

0.872

HR at T5

71.86±13.31

.106

77.71±7.09

.124

0.324

The mean values of mean arterial pressure in both the groups were comparable at the predefined time points during the study except at T5. From T1 to T2, the fall in mean MAP was 9.7% in the study group as compared to 22.3% decrease in control group while from T2 to T3, 32.5% and 23.3% increase in MAP was seen in the study and control group respectively.

 

Table 3: Mean arterial pressure in the two groups

Parameter

Study group (N=15)

Control group (N=15)

P value

Mean ± SD

P value from T1

Mean ± SD

P value from T1

MAP at T1

92±12.81

-

93.57±2.23

-

0.755

MAP at T2

83±13.18

.316

72.71±9.16

.002

0.116

MAP at T3

102.43±16.46

.083

96.43±14.54

.617

0.484

MAP at T4

97.57±13.15

.368

92.29±10.66

.751

0.425

MAP at T5

97.29±13.95

.472

82.71±5.82

.001

0.025*

The increase in mean central venous pressure was from T1 to T2, 29.3% in the study group as compared to a 1.3% decrease in control group. The central venous pressure has an increasing trend from T2 to T4 in both the groups. Mean CVP values decrease from T4 to T5 in both the groups and reach values approximately similar to the T1 levels.

 

TABLE 4: Mean central venous pressure in the two groups

Parameter

Study group (N=7)

Control group (N=7)

P value Between Groups

Mean ± SD

P value from T1

Mean ± SD

P value from T1

CVP at T1

7.86±2.41

-

7.43±1.27

-

0.685

CVP at T2

10.14±4.71

.121

7.29±2.5

.864

0.181

CVP at T3

12.86±3.24

.006

10.14±2.41

.059

0.100

CVP at T4

12.57±3.26

.008

11.14±1.22

.004

0.298

CVP at T5

8.57±3.21

.593

9.14±2.91

.212

0.733

The mean stroke volume variation in both the groups was comparable at the predefined time points during the study except at T2. From T1 to T2, no change in mean SVR is seen in the study group as compared to 7.2% fall in the control group while from T2 to T3 and T4, there was an increase in the mean SVR in both groups. The mean SVR values at T5 return to the approximately the T1 levels after CO2 exsufflation in both the groups.

Table 5: Mean stroke volume variation in the two groups

Parameter

Study group (N=7)

Control group (N=7)

P value Between Groups

Mean ± SD

P value from T1

Mean ± SD

P value from T1

SVR at T1

1503.71±674.3

-

1157.43±203.77

-

0.234

SVR at T2

1505±463.33

.995

1074.57±194.17

.100

0.043*

SVR at T3

1988.86±755.96

.041

1409.14±281.44

.063

0.096

SVR at T4

1970.57±629.86

.058

1470.57±153.49

.015

0.082

SVR at T5

1702.86±849.44

.387

1224.57±292.46

.692

0.184

mean cardiac output in both the groups was comparable at the predefined time points during the study except at T3. From T1 to T2, the fall in mean CO is 15.9% in the study group as compared to 19.7% decrease in control group while at T3 9.7% (from T2) fall in CO is noticed in study group as compared no fall in the control group.

 

Table 6: Mean cardiac output in the two groups.

Parameter

Study group (N=7)

Control group (N=7)

P value Between Groups

Mean ± SD

P value from T1

Mean ± SD

P value from T1

CO at T1

4.98±1.46

-

6.14±1.22

-

0.131

CO at T2

4.19±1.33

.180

4.93±0.54

.007

0.198

CO at T3

3.78±1.12

.092

5.07±0.93

.021

0.036*

CO at T4

3.71±1.13

.067

4.47±0.63

.005

0.146

CO at T5

4.66±1.3

.507

5.36±0.86

.029

0.259

 


Out of the 15 patients in the study group, 4 patients had episodes of hypotension requiring intervention. Only 1 patient in the study group had an episode of bradycardia at T2 requiring intervention. The patient in the control group had no intraoperative adverse event during the study. There were no episodes of clinically significant hypertension, tachycardia and arrhythmias requiring intervention in both the groups. No significant complications occurred during immediate postoperative period as well as during the hospital stay. All control groups patients were discharged from hospital on the evening of surgery. Amongst the study group patients, 5 were discharged on the POD 1 and two were discharged on POD2 of surgery. On 3 month follow up of these patient (telephonically), no mortality or morbidity has been recorded.

 

DISCUSSION

Laparoscopic cholecystectomy minimizes abdominal incision and therefore pulmonary function and diaphragmatic function remain preserved. Laparoscopic cholecystectomy decreases the incidence of postoperative ileus, helps early ambulation, has economic benefits, helps early ambulation with shorter hospital stay , early return to work and normal daily activities.3,4 Pneumoperitoneum stimulate a neuro-hormonal stress response which lead to increases heart rate, mean arterial blood pressure and systemic vascular resistance.2 Myocardial oxygen demand is increased by these factors having deletiorus effects on patients having cardiac dysfunction.6 Venous return and preload is decreased by increased intra-abdominal pressure and reverse Trendelenburg position , and it increases afterload which would eventually increase cardiac burden. These could precipitate cardiac ischemia or infarction. Ischemic heart disease patients have more chances of having arrhythmias due to CO2 pneumoperitoneum4.In most of the literature pneumoperitoneum effects on cardiovascular system has been studied on healthy subjects who can tolerate it well without much complications.7 With pneumoperitoneum the variation in cardiovascular parameters will depend on the patient's intravascular volume, the ventilatory technique , anesthetic agents employed, rate insufflations on the intra-abdominal pressure attained , amount of CO2 absorbed and patient characteristics.8 Intensive intraoperative monitoring and vigilance in the anesthetic management is of utmost importance for a smooth perioperative course in patients with cardiac dysfunction. This requires a thorough knowledge into the effect of pneumoperitoneum and reverse Trendelenburg positioning on the cardiac physiology especially with respect to patients with a diseased myocardium. According to the demographic data, the patients in the study group belong to a significantly older age group (55± 7 years) as compared to those in the control group (36 ± 10 years). This difference can be very well explained by the fact that incidence of LV systolic dysfunction and hypertension increases significantly with age.9 Patients in the study per se are predominantly females (72%). A population based study done in the north Indian population confirms a greater prevalence of cholecystitis in females as compared to males.10 Rest of the demographic parameters like weight, height, BMI and BSA were comparable in both the groups. The duration of pneumoperitoneum during the surgery was also comparable in the two groups. Kelman et al.,11 noted that cardiac filling pressures can be increased effectively with moderate increase in IAP (up to 25 cm H20). When IAP reached 40 cm H2O tachycardia, reduced CVP, hypotension and decreased cardiac output was there. There is increased cardiac output at lower IAP possibly due to increased cardiac filling pressures, which can be partially due to mechanical factors, and partially due to constriction of capacitance vessels caused by sympathetic response and effects on cardiac efferent sympathetic activity due to hypercarbia.12 Hein et al.,13 in studied 17 patients of ASA III/IV with severe cardiac dysfunction underwent laparoscopic cholecystectomy . They noticed that significantly decreased in CI (p < 0.05) following insufflation and remained low until exsufflation. After CO2 insufflation MAP, SVR, and PA occlusion pressure increased significantly (p < 0.05) .Required administration of nitroglycerin to maintain the MAP and SVR in three out of 17 patients. In another similar study, Dhoste et al.,14 noted that after induction patients had cardiovascular depression and after post peritoneal insufflation, an improvement of cardiovascular function with increases in cardiac index (+19%), heart rate (+21%), MAP (+19%). They hypothesized this effect to be as a result of a sympathetic stimulation during creation of pneumoperitoneum.14Various noninvasive monitoring techniques are available to obtain a better insight into the pathophysiological effects of creation of pneumoperitoneum. TTE is a non-invasive, cost effective technique which gives us a quick, repeatable and reliable real time image of the ongoing changes in cardiac function as well as helps us in early diagnosis of the cause of any adverse hemodynamic event encountered during surgery. It also serves as a good guide in perioperative management15. Although limitations like poor cardiac window and difficult access following placement of surgical drapes may limit measurements in all the various echocardiographic views.

 

CONCLUSION

Present study showed that laparoscopic cholecystectomy may be safely done in cardiac patients with moderate to severe left ventricular systolic dysfunction patients under the supervision of an experienced consultant anaesthesiologist. Optimization of cardiac status, administered of balanced anaesthesia and 10-12 mmHg pressure pneumoperitoneum are essential steps for patients’ safety. Life threatening complications are low and can be easily managed in hospital with adequate cardiology support.

 

REFERENCES

  • Rubert CP, Farias FV, Higa RA. Comparison between open and laparoscopic elective cholecystectomy in elderly, in a teaching hospital. Rev Col Bras Cir 2016;43:2–5.
  • Umar A, Mehta KS, Mehta N. Evaluation of hemodynamic changes using different intra-abdominal pressures for laparoscopic cholecystectomy. Indian J Surg. 2013; 75:284-289.
  • Radunovic M, Lazovic R, Popovic N, Magdelinic M, Bulajic M, Radunovic L, et al. Complications of laparoscopic cholecystectomy: Our experience from a retrospective analysis. Maced J Med Sci. 2016; 4:641-646.
  • Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE. Cardiovascular and ventilatory consequences of laparoscopic surgery. Circulation. 2017;135:700-710
  • Narayan K, Oommen R, Thomson V.S, Jose JV Assessment of left ventricular systolic function by velocity vector imaging. Indian Heart J. 2012;64:146–9.
  • Tekelioglu UY, Erdem A, Demirhan A, Akkaya A, Ozturk S, Bilgi M, et al. The prolonged effect of pneumoperitoneum on cardiac autonomic functions during laparoscopic surgery; Eur Rev Med Pharmacol Sci. 2013; 17:895-902.
  • Hypolito O, Azevedo JL, Gama F, Azevedo O, Miyahira SA b., Pires OC ésa., et al. Effects of elevated artificial pneumoperitoneum pressure on invasive blood pressure and levels of blood gases. Brazilian J Anesthesiol. 2014; 64:98-104.
  • Sadhu S, Sarkar S, Jahangir TA, Verma R, Shaikh F, Dubey SK, et al. Laparoscopic cholecystectomy in patients with cardiac dysfunction. Indian J Surg. 2011;73:90-95
  • I Raymond, F Pedersen, F Sten Sgaard, A Green M, Bush, C Tuxen etal. Prevalence of impaired left ventricular systolic functiong and heart failure. J Heart 2003; 89: 1422-9
  • Sayeed U, Palepu J, Vinay D, Chiranjeeva K, Latendu S Tarun KR etal. Population-based study to estimate prevalence and determine risk factors of gall bladder. HPB Oxford. 2011; 13: 117-125
  • Kelman GR, Swapp GH, Smith I, et al. Cardiac output and arterial blood-gas tension during laparoscopy. Br J Anaesth.1972;44:1155-62
  • Rasmussen JP, Dauchot PJ, Depalma RG, Sorensen B, Regula G, Anton AH, et al. Cardiac function and hypercarbia. Arch Surg. 1978; 113;1196-1200.
  • Hein HAT, Joshi GP, Ramsay MAE, Fox LG, Gawey BJ, Hellman CL, et al. Hemodynamic changes during laparoscopic cholecystectomy in patients with severe cardiac disease. J Clin Anesth. 1997;9:261-265.
  • Dhoste K, Lacoste L, Karayan J, Lehuede MS, Thomas D, Fusciardi J. Haemodynamic and ventilatory changes during laparoscopic cholecystectomy in elderly ASA III patients. Can J Anaesth. 1996; 43:783-788.
  • Jørgensen MRS, Juhl-Olsen P, Frederiksen CA, Sloth E. Transthoracic echocardiography in the perioperative setting. Curr Opin Anaesthesiol. 2016; 29:46-54.






























 








 




 








 

 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.